The DOI matches its Crossref record; the references it cites are not checked yet.
Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology
Abstract
Attention deficit hyperactivity disorder (ADHD) is a common condition with a high societal burden. The present guidelines summarise current literature, generating expert consensus recommendations for the treatment of ADHD in children and adults. These guidelines also provide a review of recent research in the fields of neuroimaging, neuropsychology and genetics of ADHD. Novel discoveries in these areas have informed physiological models for the disease. Since the publication of the previous British Association for Psychopharmacology guidelines in 2008, new drugs have been licensed and further compounds are being investigated. The publication of randomised controlled trials of psychological interventions has contributed to the range of treatment options for ADHD. As the disorder has been diagnosed more frequently there has been greater focus on comorbid conditions and how they impact treatment. Services have continued to develop for the treatment of ADHD in adults and care agreements have been introduced to facilitate access to treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Professional associations have endorsed and published guidelines for diagnosing ADHD”
From The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder (2021) · cites this paper as Bolea-Alamanac et al., 2014
In the citing paper
“Psychostimulants, including amphetamines and methylphenidate, are first-line pharmacotherapies for individuals with attention-deficit/hyperactivity disorder (ADHD).”
In the citing paper
“Furthermore, current guidelines are inconsistent in their treatment recommendations.9, 10, 11, 12, 13, 14”
Citations
The citation lists are queued
They are fetched later and appear here then.
References 176 · Cited by 287
Research works printed but not linked: 6
- Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA), 2011, Canadian ADHD Practice Guidelines
- Coles CD, 2001, Alcohol Res Health, 25, 199
- Fliers EA, 2011, Ned Tijdschr Geneeskd, 155, A3559
- NICE, 2008, Attention Deficit Hyperactivity Disorder: The NICE guideline on diagnosis and managment of ADHD in children young people and adults
- Sonuga-Barke E, 2010, J Am Acad Child Adolesc Psychiatry, 49, 345
- Thurstone C, 2010, J Am Acad Child Adolesc Psychiatry, 49, 573
Metadata
- Authors
- Bolea-Alamañac, B., Nutt, D. J., Adamou, M., Asherson, P., Bazire, S., Coghill, D., Heal, D., Müller, U., Nash, J., Santosh, P., Sayal, K., Sonuga-Barke, E., Young, S. J., & for the Consensus Group
- Affiliations
- University of Bristol, Bristol, UK
- Imperial College London (GB)
- South West Yorkshire Partnership NHS Foundation Trust (GB)
- Institute of Psychiatry, London, UK
- Norfolk and Suffolk NHS Foundation Trust (GB)
- University of Dundee (GB)
- RenaSci (United Kingdom) (GB)
- University of Cambridge (GB)
- North Wales Hospital (GB)
- Centre for Interventional Paediatric Psychopharmacology, London, UK
- University of Nottingham (GB)
- University of Southampton (GB)
- ORCID
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2014-02-12
- Volume
- 28
- Issue
- 3
- Pages
- 179-203
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2104582464
- Semantic Scholar
- 0789d94a69146ec62b3905f2f4501e5248cf658e
- Cited by
- 287
- References
- 176
- Citations by year
- 2026: 10 · 2025: 18 · 2024: 16 · 2023: 18 · 2022: 16 · 2021: 23 · 2020: 39 · 2019: 19 · 2018: 30 · 2017: 39 · 2016: 29 · 2015: 19 · 2014: 10
- FWCI
- 24.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Keywords
- attention deficit hyperactivity disorder, pharmacotherapy, ADHD medication, children, adults, neuroimaging, neuropsychology, psychological intervention, comorbidities, care agreements, treatment access, expert consensus recommendations
- MeSH terms
- Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Humans, Evidence-Based Medicine, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology. https://app.cochat.ai/papers/10.1177/0269881113519509
- The paper
- Bolea-Alamañac, B., Nutt, D. J., Adamou, M., Asherson, P., Bazire, S., Coghill, D., Heal, D., Müller, U., Nash, J., Santosh, P., Sayal, K., Sonuga-Barke, E., Young, S. J., & for the Consensus Group. (2014). Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology. https://doi.org/10.1177/0269881113519509
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.